Search results
Julie Louise Gerberding (born August 22, 1955) is an American infectious disease expert who was the first woman to serve as the director of the U.S. Centers for Disease Control and Prevention (CDC). As of May 2022, she is the CEO of the Foundation for the National Institutes of Health (FNIH).
Mar 1, 2022 · Dr. Gerberding currently serves as Chief Patient Officer and Executive Vice President, Population Health & Sustainability at Merck, where she is responsible for patient engagement, corporate social responsibility, and other functions.
People also ask
Who is Dr Julie Gerberding?
Who is Jennifer Gerberding?
Where did Dr Gerberding go to medical school?
Year: 2002. Achievement: Dr. Julia Louise Gerberding is the first woman to be appointed director of the Centers for Disease Control (CDC) in Atlanta, Georgia.
Mar 1, 2022 · KENILWORTH, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Dr. Julie L. Gerberding, chief patient officer and executive vice president, population health and sustainability, will be retiring from Merck in May 2022.
Mar 18, 2022 · The Foundation for the National Institutes of Health appointed Dr. Julie Louise Gerberding as its next chief executive officer. She will assume her role on May 16.
Dec 10, 2014 · today announced the appointment of Dr. Julie Gerberding, 59, as executive vice president for strategic communications, global public policy and population health, effective Dec. 15. In this newly created Executive Committee position, Gerberding, who most recently served as president of Merck Vaccines, will be responsible for Merck’s global
Biography. Dr. Julie Louise Gerberding is the Chief Executive Officer of the Foundation for the National Institutes of Health (FNIH). The FNIH creates and manages research alliances with public and private institutions in support of the mission of the NIH to enhance health, lengthen life, and reduce illness and disability.
